Anklyosing Spondylitis
3 clinical trials · Condition
◉ Watch Anklyosing Spondylitis
| Record | Firm | Date |
|---|---|---|
| CALLY Index and Disease Activity in Ankylosing Spondylitis (NCT07509463) | Bursa City Hospital | 2022-01-01 |
| 16 Week Efficacy and 5 Year Long Term Efficacy, Safety and Tolerability of Secukinumab in Patients With Active Ankylosing Spondylitis (NCT01649375) | Novartis Pharmaceuticals | 2012-10-18 |
Track Anklyosing Spondylitis automatically
Every clearance here is in the API, with alerts when new ones post.